Eye | |||||
---|---|---|---|---|---|
Eye / Bacterial eye infection | |||||
azithromycin | On Formulary | ||||
Oral suspension | |||||
Azithromycin (Non-proprietary) | On Formulary | ||||
Zithromax (Pfizer Ltd) | On Formulary | ||||
Eye drops | |||||
Azyter (Thea Pharmaceuticals Ltd) | On Formulary | ||||
cefuroxime | On Formulary | ||||
Powder for solution for injection | |||||
Aprokam (Thea Pharmaceuticals Ltd) | Hospital Only | ||||
chloramphenicol | On Formulary | ||||
Ear drops | |||||
Chloramphenicol (Non-proprietary) | On Formulary | ||||
Eye drops | |||||
Chloramphenicol (Non-proprietary) | On Formulary | ||||
Eye ointment | |||||
Chloramphenicol (Non-proprietary) | On Formulary | ||||
ciprofloxacin | On Formulary | ||||
Oral suspension | |||||
Ciproxin (Bayer Plc) | On Formulary | ||||
Eye drops | |||||
Ciloxan (Novartis Pharmaceuticals UK Ltd) | On Formulary | ||||
fusidic acid | On Formulary | ||||
gentamicin | On Formulary | ||||
levofloxacin | On Formulary | ||||
ofloxacin | On Formulary | ||||
tobramycin | On Formulary |
NICE TA276 |
|||
Eye / Intravitreal Antibacterials | |||||
Amikacin Intravitreal | On Formulary | ||||
Ceftazidime Intravitreal | On Formulary | ||||
Vancomycin Intravitreal | On Formulary | ||||
Eye / Ophthalmic herpes simplex | |||||
aciclovir | On Formulary | ||||
Eye / Allergic conjunctivitis | |||||
azelastine hydrochloride | On Formulary | ||||
diclofenac sodium | On Formulary | ||||
Akis brand of Diclofenac Injection to replace Voltarol
Akis brand of Diclofenac to replace Voltarol on the formulary, Akis does not require a buffer to dilute pior to administration
|
|||||
ketotifen | Off Formulary | ||||
lodoxamide | On Formulary | ||||
olopatadine | On Formulary | ||||
sodium cromoglicate | On Formulary | ||||
Eye drops | |||||
Sodium cromoglicate (Non-proprietary) | On Formulary | ||||
Eye / Inflammatory eye conditions | |||||
adalimumab | Hospital Only |
NICE TA187 NICE TA329 NICE TA199 NICE TA195 NICE TA375 NICE TA715 NICE TA383 NICE TA392 NICE TA146 NICE TA460 |
|||
betamethasone | On Formulary | ||||
Betesil Medicated Plaster - Inflammatory Skin Disorders (November 2022)
Approved at NEL FPG (Nov 2022) Betesil® 2.250mg medicated plaster is the only potent corticosteroid indicated in adults for the treatment of inflammatory skin disorders. The plaster is licensed to use for a maximum of 30 days at a time, with a maximum of 6 plasters being used at any one time. Plasters may be changed once every 24 hours. Amber-may be prescribed by or on the advice of a specialist |
|||||
betamethasone with neomycin | On Formulary | ||||
ciclosporin | On Formulary |
NICE TA369 |
|||
Oral solution | |||||
Neoral (Novartis Pharmaceuticals UK Ltd) | On Formulary | ||||
Solution for infusion | |||||
Sandimmun (Novartis Pharmaceuticals UK Ltd) | Hospital Only | ||||
dexamethasone | On Formulary |
NICE TA229 NICE TA824 NICE TA460 |
|||
Dexamethasone intravitreal implant (Ozurdex) for treating diabetic macular oedema - December 2022 - (NICE TA 824)
Approved at NEL FPG in line with NICE TA 824. Dexamethasone intravitreal implant (Ozurdex) is recommended as an option for treating visual impairment caused by diabetic macular oedema in adults only if their condition has not responded well enough to, or if they cannot have non-corticosteroid therapy. This is an update and replacement of TA 349 |
|||||
Eye drops | |||||
Dexamethasone (Non-proprietary) | On Formulary | ||||
Maxidex (Novartis Pharmaceuticals UK Ltd) | On Formulary | ||||
dexamethasone with hypromellose, neomycin and polymyxin B sulfate | On Formulary | ||||
Eye drops | |||||
Maxitrol (Novartis Pharmaceuticals UK Ltd) | On Formulary | ||||
Eye ointment | |||||
Maxitrol (Novartis Pharmaceuticals UK Ltd) | On Formulary | ||||
fluorometholone | On Formulary | ||||
Eye drops | |||||
FML Liquifilm (AbbVie Ltd) | On Formulary | ||||
nepafenac | Hospital Only | ||||
Eye drops | |||||
Nevanac (Novartis Pharmaceuticals UK Ltd) | Hospital Only | ||||
Nepafanac eyedrops
|
|||||
prednisolone | On Formulary | ||||
Eye drops | |||||
Prednisolone (Non-proprietary) | On Formulary | ||||
Pred Forte (AbbVie Ltd) | On Formulary | ||||
Eye / Anterior uveitis | |||||
atropine sulfate | On Formulary | ||||
Solution for injection | |||||
Atropine sulfate (Non-proprietary) | On Formulary | ||||
Eye drops | |||||
Atropine sulfate (Non-proprietary) | On Formulary | ||||
cyclopentolate hydrochloride | On Formulary | ||||
Eye drops | |||||
Cyclopentolate hydrochloride (Non-proprietary) | On Formulary | ||||
Mydrilate (Esteve Pharmaceuticals Ltd) | On Formulary | ||||
homatropine hydrobromide | On Formulary | ||||
Eye / Eye procedures | |||||
acetylcholine chloride | On Formulary | ||||
apraclonidine | On Formulary | ||||
Eye drops | |||||
Iopidine (Essential Pharma Ltd) | On Formulary | ||||
atropine sulfate | On Formulary | ||||
Solution for injection | |||||
Atropine sulfate (Non-proprietary) | On Formulary | ||||
Eye drops | |||||
Atropine sulfate (Non-proprietary) | On Formulary | ||||
cyclopentolate hydrochloride | On Formulary | ||||
Eye drops | |||||
Cyclopentolate hydrochloride (Non-proprietary) | On Formulary | ||||
Mydrilate (Esteve Pharmaceuticals Ltd) | On Formulary | ||||
fluorescein sodium | On Formulary | ||||
Eye drops | |||||
Fluorescein sodium (Non-proprietary) | Hospital Only | ||||
Fluoroscein ENT
Fluorescein ENT-Nov 2012 |
|||||
lidocaine hydrochloride | |||||
Medicated plaster | |||||
Ralvo (Grunenthal Ltd) | Off Formulary | ||||
Versatis (Grunenthal Ltd) | Off Formulary | ||||
phenylephrine hydrochloride | On Formulary | ||||
Eye drops | |||||
Phenylephrine hydrochloride (Non-proprietary) | On Formulary | ||||
tropicamide | On Formulary | ||||
Eye drops | |||||
Tropicamide (Non-proprietary) | Hospital Only | ||||
Mydriacyl (Alcon Eye Care UK Ltd) | On Formulary | ||||
tropicamide with phenylephrine and lidocaine | Hospital Only | ||||
Mydrane for Cataract surgery, June 2018
Accepted on the DTC but only within a defined QI project. |
|||||
Eye / Post-operative pain and inflammation | |||||
diclofenac sodium | On Formulary | ||||
Akis brand of Diclofenac Injection to replace Voltarol
Akis brand of Diclofenac to replace Voltarol on the formulary, Akis does not require a buffer to dilute pior to administration
|
|||||
flurbiprofen | Off Formulary | ||||
ketorolac trometamol | On Formulary | ||||
Eye drops | |||||
Acular (AbbVie Ltd) | On Formulary | ||||
loteprednol etabonate | On Formulary | ||||
Eye / Glaucoma and ocular hypertension | |||||
acetazolamide | On Formulary | ||||
Modified-release capsule | |||||
Diamox SR (Advanz Pharma) | On Formulary | ||||
Powder for solution for injection | |||||
Diamox (Advanz Pharma) | Hospital Only | ||||
apraclonidine | On Formulary | ||||
Eye drops | |||||
Iopidine (Essential Pharma Ltd) | On Formulary | ||||
betaxolol | On Formulary | ||||
Eye drops | |||||
Betaxolol (Non-proprietary) | On Formulary | ||||
Betoptic (Immedica Pharma AB) | On Formulary | ||||
bimatoprost | On Formulary | ||||
Eye drops | |||||
Lumigan (AbbVie Ltd) | On Formulary | ||||
brimonidine tartrate | On Formulary | ||||
Eye drops | |||||
Brimonidine tartrate (Non-proprietary) | On Formulary | ||||
Alphagan (AbbVie Ltd) | On Formulary | ||||
dorzolamide | On Formulary | ||||
Eye drops | |||||
Trusopt (Santen UK Ltd) | On Formulary | ||||
latanoprost | On Formulary | ||||
Eye drops | |||||
Xalatan (Viatris UK Healthcare Ltd) | On Formulary | ||||
latanoprost with timolol | |||||
Eye drops | |||||
Xalacom (Viatris UK Healthcare Ltd) | On Formulary | ||||
levobunolol hydrochloride | On Formulary | ||||
Eye drops | |||||
Betagan (AbbVie Ltd) | On Formulary | ||||
pilocarpine | On Formulary | ||||
Eye drops | |||||
Pilocarpine (Non-proprietary) | On Formulary | ||||
timolol maleate | On Formulary | ||||
Eye drops | |||||
Timolol maleate (Non-proprietary) | On Formulary | ||||
Eysano (Aspire Pharma Ltd) | On Formulary | ||||
Timoptol (Santen UK Ltd) | On Formulary | ||||
Tiopex (Thea Pharmaceuticals Ltd) | On Formulary | ||||
Once-daily preparations
Long acting preparations of timolol are used in dermatology for cutaneous haemangioma |
|||||
Eye gel | |||||
Timoptol-LA (Santen UK Ltd) | On Formulary | ||||
travoprost | On Formulary | ||||
Eye drops | |||||
Travatan (Novartis Pharmaceuticals UK Ltd) | On Formulary | ||||
Eye / Optic neuropathy | |||||
idebenone | Hospital Only | ||||
Eye / Vitreomacular traction | |||||
ocriplasmin [Specialist drug] | Hospital Only |
NICE TA297 |
|||
Eye / Macular oedema | |||||
aflibercept [Specialist drug] | Hospital Only |
NICE TA294 NICE TA305 NICE TA346 NICE TA409 NICE TA486 NICE TA307 |
|||
Solution for injection | |||||
Eylea (Bayer Plc) | Hospital Only | ||||
Solution for infusion | |||||
Zaltrap (Sanofi) | Hospital Only | ||||
brolucizumab [Specialist drug] | Hospital Only |
NICE TA672 NICE TA820 |
|||
Brolucizumab-Diabetic macular oedema (NICE TA 820) (November 2022)
Approved at NEL FPG for diabetic macular oedema. Barts Health consultants not wish to use it. |
|||||
dexamethasone | On Formulary |
NICE TA229 NICE TA824 NICE TA460 |
|||
Dexamethasone intravitreal implant (Ozurdex) for treating diabetic macular oedema - December 2022 - (NICE TA 824)
Approved at NEL FPG in line with NICE TA 824. Dexamethasone intravitreal implant (Ozurdex) is recommended as an option for treating visual impairment caused by diabetic macular oedema in adults only if their condition has not responded well enough to, or if they cannot have non-corticosteroid therapy. This is an update and replacement of TA 349 |
|||||
faricimab [Specialist drug] | Hospital Only |
NICE TA799 NICE TA800 |
|||
Faricimab for treating Diabetic Macular Oedema
Approved via chair's action 15th August 2022 for treating diabetic macular oedema (NICE TA 799)
Hospital Only |
|||||
Faricimab for treating Wet Age-Related Macular Degeneration
Approved via chair's action 15th August 2022 for treating Wet age-related macular degeneration (NICE TA 800)
Hospital Only |
|||||
fluocinolone acetonide | Hospital Only |
NICE TA301 NICE TA613 NICE TA590 |
|||
ranibizumab [Specialist drug] | Hospital Only |
NICE TA298 NICE TA283 NICE TA274 NICE TA155 |
|||
Ranibizumab biosimilar switch (Lucentis to Ongavia) (October 2022)
NEL FPG Approved to use as per the originator (Lucentis) The treatment of wet age-related macular degeneration (wAMD), the treatment of visual impairment due to diabetic macular oedema (DMO), the treatment of proliferative diabetic retinopathy, the treatment of visual impairment due to macular oedema secondary to retinal vein occlusion (bRVO or cRVO), the treatment of visual impairment due to choroidal neovascularisation. |
|||||
Eye / Macular degeneration | |||||
aflibercept [Specialist drug] | Hospital Only |
NICE TA294 NICE TA305 NICE TA346 NICE TA409 NICE TA486 NICE TA307 |
|||
Solution for injection | |||||
Eylea (Bayer Plc) | Hospital Only | ||||
Solution for infusion | |||||
Zaltrap (Sanofi) | Hospital Only | ||||
brolucizumab [Specialist drug] | Hospital Only |
NICE TA672 NICE TA820 |
|||
Brolucizumab-Diabetic macular oedema (NICE TA 820) (November 2022)
Approved at NEL FPG for diabetic macular oedema. Barts Health consultants not wish to use it. |
|||||
faricimab [Specialist drug] | Hospital Only |
NICE TA799 NICE TA800 |
|||
Faricimab for treating Diabetic Macular Oedema
Approved via chair's action 15th August 2022 for treating diabetic macular oedema (NICE TA 799)
Hospital Only |
|||||
Faricimab for treating Wet Age-Related Macular Degeneration
Approved via chair's action 15th August 2022 for treating Wet age-related macular degeneration (NICE TA 800)
Hospital Only |
|||||
ranibizumab [Specialist drug] | Hospital Only |
NICE TA298 NICE TA283 NICE TA274 NICE TA155 |
|||
Ranibizumab biosimilar switch (Lucentis to Ongavia) (October 2022)
NEL FPG Approved to use as per the originator (Lucentis) The treatment of wet age-related macular degeneration (wAMD), the treatment of visual impairment due to diabetic macular oedema (DMO), the treatment of proliferative diabetic retinopathy, the treatment of visual impairment due to macular oedema secondary to retinal vein occlusion (bRVO or cRVO), the treatment of visual impairment due to choroidal neovascularisation. |
|||||
verteporfin [Specialist drug] | Hospital Only | ||||
Eye / Dry eye conditions | |||||
acetylcysteine | On Formulary | ||||
Acetylcysteine
THIS DRUG IS FOR HOSPITAL USE ONLY when used for: Reduction of mucus viscosity and facilitate expectoration. |
|||||
Solution for infusion | |||||
Parvolex (Phoenix Labs Ltd) | Off Formulary | ||||
Eye drops | |||||
Ilube (Rayner Pharmaceuticals Ltd) | Off Formulary | ||||
carbomers | On Formulary | ||||
Eye drops | |||||
Viscotears (Bausch & Lomb UK Ltd) | On Formulary | ||||
carmellose sodium | On Formulary | ||||
Eye drops | |||||
Carmellose sodium (Non-proprietary) | On Formulary | ||||
Carmize (Aspire Pharma Ltd) | On Formulary | ||||
Cellusan (Farmigea S.p.A.) | On Formulary | ||||
Celluvisc (AbbVie Ltd) | On Formulary | ||||
Lumecare (Medicom Healthcare Ltd) | On Formulary | ||||
Optive (Allergan Ltd) | On Formulary | ||||
Optive Plus (Allergan Ltd) | On Formulary | ||||
Xailin Fresh (Visufarma UK Ltd) | On Formulary | ||||
hydroxyethylcellulose | On Formulary | ||||
Eye drops | |||||
Hydroxyethylcellulose (Non-proprietary) | On Formulary | ||||
hypromellose | On Formulary | ||||
Eye drops | |||||
Hypromellose (Non-proprietary) | On Formulary | ||||
liquid paraffin with white soft paraffin and wool alcohols | On Formulary | ||||
paraffin, yellow, soft | On Formulary | ||||
Eye ointment | |||||
Paraffin, yellow, soft (Non-proprietary) | On Formulary | ||||
polyvinyl alcohol | On Formulary | ||||
Eye drops | |||||
Liquifilm Tears (Allergan Ltd) | On Formulary | ||||
sodium chloride | On Formulary | ||||
Eye drops | |||||
Sodium chloride (Non-proprietary) | On Formulary | ||||
Hypersal (Ennogen Healthcare Ltd) | On Formulary | ||||
ODM5 (Kestrel Ophthalmics Ltd) | On Formulary |